Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.
2.
3.

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f. Review.

PMID:
18480677
4.

[Hereditary basis of attention deficit and hyperactivity disorder].

Manor I, Ebstein R.

Harefuah. 2000 Nov;139(9-10):382-5. Review. Hebrew. No abstract available.

PMID:
11341221
5.

Genes and attention deficit hyperactivity disorder.

Swanson J, Posner M, Fusella J, Wasdell M, Sommer T, Fan J.

Curr Psychiatry Rep. 2001 Apr;3(2):92-100. Review.

PMID:
11276403
6.

Pharmacogenetic approach for a better drug treatment in children.

Polanczyk G, Bigarella MP, Hutz MH, Rohde LA.

Curr Pharm Des. 2010;16(22):2462-73. Review.

PMID:
20513229
7.

[Neuropsychopharmacological effects of methylphenidate].

Ikeda K, Takamatsu Y, Hagino Y, Sora I.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Jun;29(3):121-3. Review. Japanese.

PMID:
19663262
8.

Genetic polymorphisms of serotonin and dopamine transporters in mental disorders.

Ueno S.

J Med Invest. 2003 Feb;50(1-2):25-31. Review.

PMID:
12630565
9.

Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD.

Swanson JM, Volkow ND.

Behav Brain Res. 2002 Mar 10;130(1-2):73-8. Review.

PMID:
11864720
10.

Molecular genetics of attention-deficit/hyperactivity disorder.

Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P.

Biol Psychiatry. 2005 Jun 1;57(11):1313-23. Epub 2005 Jan 21. Review.

PMID:
15950004
11.

A review of the biological bases of ADHD: what have we learned from imaging studies?

Durston S.

Ment Retard Dev Disabil Res Rev. 2003;9(3):184-95. Review.

PMID:
12953298
12.

The dopamine transporter and attention-deficit/hyperactivity disorder.

Madras BK, Miller GM, Fischman AJ.

Biol Psychiatry. 2005 Jun 1;57(11):1397-409. Epub 2005 Jan 5. Review.

PMID:
15950014
13.

Attention deficit and hyperactivity disorder: review of genetic association studies.

Galili-Weisstub E, Segman RH.

Isr J Psychiatry Relat Sci. 2003;40(1):57-66. Review.

PMID:
12817670
14.

Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.

Contini V, Rovaris DL, Victor MM, Grevet EH, Rohde LA, Bau CH.

Eur Neuropsychopharmacol. 2013 Jun;23(6):555-60. doi: 10.1016/j.euroneuro.2012.05.006. Epub 2012 Jun 17. Review.

PMID:
22709890
15.

Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.

Quinn D.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S62-6. doi: 10.1097/JCP.0b013e3181744aa6. Review.

PMID:
18480679
16.

Genetics of the serotonergic system in suicidal behavior.

Arango V, Huang YY, Underwood MD, Mann JJ.

J Psychiatr Res. 2003 Sep-Oct;37(5):375-86. Review.

PMID:
12849930
17.

Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.

Anderson VR, Scott LJ.

Drugs. 2006;66(8):1117-26. Review.

PMID:
16789796
18.

Molecular genetic studies of ADHD: 1991 to 2004.

Bobb AJ, Castellanos FX, Addington AM, Rapoport JL.

Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):109-25. Review.

PMID:
15700344
19.

Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002.

Rapoport JL, Inoff-Germain G.

J Atten Disord. 2002;6 Suppl 1:S57-60. Review.

PMID:
12685519
20.

Serum and brain concentrations of methylphenidate: implications for use and abuse.

Swanson JM, Volkow ND.

Neurosci Biobehav Rev. 2003 Nov;27(7):615-21. Review.

PMID:
14624806
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk